Internal Medicine, Endocrinology, Diabetes, & Metabolism · Omaha, NE
NPI
1750470118
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
Emile @ 42nd St
Omaha, NE, 68198
Phone (402) 559-8700
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
708 services
Medicare patients, 2024
538
Average age 74
Drug cost, 2024
$844K
908 prescriptions
Company payments, 2025
$641
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura A Graeff-Armas was code 99214 (office e&m - established), 344 times for 306 patients. In total Laura A Graeff-Armas billed 708 services in 14 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 344 | 306 | $62.18 | $21K |
| 99204 Office E&M - New | Facility | 90 | 90 | $73.41 | $6,607 |
| 99222 Hospital E&M - Initial | Facility | 63 | 63 | $94.56 | $5,958 |
| 99232 Hospital E&M - Subsequent | Facility | 43 | 26 | $57.29 | $2,463 |
| 99213 Office E&M - Established | Facility | 40 | 39 | $35.34 | $1,414 |
| 99233 Hospital E&M - Subsequent | Facility | 39 | 16 | $84.87 | $3,310 |
| 99221 Hospital E&M - Initial | Facility | 28 | 28 | $53.52 | $1,499 |
| 99215 Office E&M - Established | Facility | 24 | 21 | $105.14 | $2,523 |
| 99223 Hospital E&M - Initial | Facility | 16 | 16 | $123.26 | $1,972 |
By year: 2022 $54K for 789 services; 2023 $43K for 627 services; 2024 $48K for 708 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura A Graeff-Armas prescribed most often to Medicare patients was Forteo (Teriparatide), with 133 prescriptions and refills. In total Laura A Graeff-Armas wrote 908 Medicare prescriptions that cost $844K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Forteo Teriparatide | 133 | 133 | 21 | $528K |
| Alendronate Sodium Generic | 91 | 235 | 32 | $872 |
| Levothyroxine Sodium Generic | 83 | 174 | 26 | $990 |
| Teriparatide Generic | 44 | 44 | Under 11 | $119K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 42 | 123 | 18 | $2,378 |
| Ibandronate Sodium Generic | 36 | 89 | 14 | $1,097 |
| Ozempic Semaglutide | 30 | 43 | Under 11 | $39K |
| Testosterone Generic | 27 | 32 | Under 11 | $5,283 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 24 | 67 | 11 | $1,495 |
| Humalog Kwikpen U-100 Insulin Lispro | 22 | 34 | Under 11 | $6,721 |
| Methimazole Generic | 18 | 44 | Under 11 | $154 |
| Trulicity Dulaglutide | 18 | 23 | Under 11 | $16K |
| Synthroid Levothyroxine Sodium | 16 | 48 | Under 11 | $1,867 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 15 | 41 | Under 11 | $879 |
| Prednisone Generic | 15 | 29 | Under 11 | $138 |
Brand drugs: 399 claims; generic drugs: 393 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura A Graeff-Armas $641 ($641 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $288.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.